We are live on ! Find out more
SPPI

Spectrum Pharmaceuticals Inc
SPPI

Delisted

SPPI was delisted on the 31st of July, 2023.

Back to rankings

101 hedge funds and large institutions have $92.5M invested in Spectrum Pharmaceuticals Inc in 2022 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 17 increasing their positions, 47 reducing their positions, and 56 closing their positions.

New
Increased
Maintained
Reduced
Closed

414% more call options, than puts

Call options by funds: $432K | Put options by funds: $84K

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

26% less capital invested

Capital invested by funds: $125M → $92.5M (-$32.3M)

29% less funds holding

Funds holding: 142 → 101 (-41)

64% less repeat investments, than reductions

Existing positions increased: 17 | Existing positions reduced: 47

73% less first-time investments, than exits

New positions opened: 15 | Existing positions closed: 56

Holders
101
Holders Change
-41
Holders Change %
-28.87%
% of All Funds
1.59%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
15
Increased
17
Reduced
47
Closed
56
Calls
$432K
Puts
$84K
Net Calls
+$348K
Net Calls Change
+$654K

Top Buyers

Rank Fund Capital Flow
1
AC
Armistice Capital
New York
+$6.85M
2
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$6.43M
3
Renaissance Technologies
Renaissance Technologies
New York
+$528K
4
CM
CM Management
Florida
+$414K
5
SIG
Sargent Investment Group
Maryland
+$368K

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$13.3M
2
Bank of America
Bank of America
North Carolina
-$6.28M
3
Goldman Sachs
Goldman Sachs
New York
-$2.46M
4
Millennium Management
Millennium Management
New York
-$2.05M
5
Vanguard Group
Vanguard Group
Pennsylvania
-$1.41M
Name Holding Trade Value Shares
Change 		Change in
Stake
SA
126
Syntax Advisors
New York
– -$37K -29,181 Closed
VCG
127
Vantage Consulting Group
Virginia
– -$37K -29,181 Closed
BFM
128
Boothbay Fund Management
New York
– -$35K -27,556 Closed
Axa
129
Axa
France
– -$33K -26,100 Closed
MOACM
130
Mutual of America Capital Management
New York
– -$28K -22,400 Closed
TRSOTSOK
131
Teachers Retirement System of the State of Kentucky
Kentucky
– -$28K -21,722 Closed
PHK
132
Point72 Hong Kong
Hong Kong
– -$21K -16,752 Closed
PA
133
Profund Advisors
Maryland
– -$21K -16,458 Closed
Balyasny Asset Management
134
Balyasny Asset Management
Illinois
– -$20K -15,597 Closed
CGH
135
Crossmark Global Holdings
Texas
– -$20K -15,500 Closed
Tudor Investment Corp
136
Tudor Investment Corp
Connecticut
– -$16K -12,893 Closed
DWT
137
Dorsey & Whitney Trust
South Dakota
– -$15K -11,481 Closed
Commonwealth Equity Services
138
Commonwealth Equity Services
Massachusetts
– -$13K -10,850 Closed
TCM
139
Teza Capital Management
Illinois
– -$13K -10,352 Closed
MIM
140
MetLife Investment Management
New Jersey
– -$10.8K -8,517 Closed
FAG
141
Fortitude Advisory Group
Washington
– -$10K -7,600 Closed
QT
142
Quantbot Technologies
New York
– -$5.22K -5,672 -98%
Carson Wealth (CWM LLC)
143
Carson Wealth (CWM LLC)
Nebraska
– -$3.96K -4,295 -100%
Fifth Third Bancorp
144
Fifth Third Bancorp
Ohio
– -$1K -1,177 Closed
STCOSD
145
Sageworth Trust Company of South Dakota
South Dakota
– -$390 -424 -82%
CA
146
CoreCap Advisors
Michigan
– -$1K -24 Closed
LC
147
Lindbrook Capital
California
– +$1 +1 New
CAL
148
Capital Advisors Ltd
Ohio
– +$98 +106 New
2 3 4 5
6

SPPI Hedge Fund Activity: Q1 2022 in Review

101 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Spectrum Pharmaceuticals Inc (SPPI) for Q1 2022, worth a combined $92.5M — down 26% from $125M a quarter earlier.

Sellers outnumbered buyers: 56 funds closed out of SPPI and 15 opened new positions — a net loss of 41 holders — while 47 trimmed existing stakes and 17 added.

The largest buyer was Armistice Capital, adding an estimated $6.85M. The largest seller was BlackRock, cutting an estimated $13.3M.

  • 101 institutional investors held Spectrum Pharmaceuticals Inc (SPPI) as of Q1 2022, down from 142 in Q4 2021.
  • Funds reported $92.5M of Spectrum Pharmaceuticals Inc stock for Q1 2022, down 26% quarter-over-quarter.
  • 15 funds opened new Spectrum Pharmaceuticals Inc positions in Q1 2022 and 56 closed out, a net change of -41 holders.
  • The largest Spectrum Pharmaceuticals Inc buyer in Q1 2022 was Armistice Capital, an estimated $6.85M added.
  • The largest Spectrum Pharmaceuticals Inc seller in Q1 2022 was BlackRock, an estimated $13.3M sold.

Based on aggregated 13F filings for Q1 2022.